Stock comparison
Koninklijke Philips N.V.
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
PHG
Koninklijke Philips N.V.
Market cap
$25.66B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | PHG | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 38D | 71B | UTHR |
| Benjamin Graham | 36D | 76B | UTHR |
| Philip Fisher | 38D | 76B | UTHR |
| Peter Lynch | 44D | 62C | UTHR |
| Joel Greenblatt | 30F | 46D | UTHR |
| Charlie Munger | 36D | 64C | UTHR |
| Terry Smith | 33F | 64C | UTHR |
Side-by-side metrics
| Metric | PHG | UTHR |
|---|---|---|
| Market cap | $25.66B | $24.13B |
| P/E (TTM) | 21.4x | 19.2x |
| EV/EBIT | 18.5x | 15.2x |
| ROIC (TTM) | 5.76% | 18.81% |
| Gross margin | 45.2% | 86.58% |
| Net margin | 5.5% | 40.61% |
| Revenue CAGR 5y | 0.97% | 17.22% |
| EPS CAGR 5y | 9.12% | 29.84% |
| Debt / Equity | 0.7x | - |
| Dividend yield | 3.89% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PHG leads on
- Dividend yield3.89%vs 0.0%+100%
- Market cap$25.66Bvs $24.13B+6%
UTHR leads on
- Debt / Equity-vs 0.7x+100%
- Revenue CAGR 5y17.22%vs 0.97%+94%
- Net margin40.61%vs 5.5%+86%
- EPS CAGR 5y29.84%vs 9.12%+69%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.